Temprian Therapeutics is a developer of therapies intended for autoimmune disease. The company offers DNA-based treatment by injecting DNA coding for a modified heat shock protein to stop the autoimmune response at the outset, enabling consumers to get treatments for vitiligo disease.
Partial Data by Infogroup (c) 2024. All rights reserved.